Dialysis does not create a simple yes-or-no answer about platelet-rich plasma. An elective musculoskeletal PRP injection needs a careful review of the painful condition, infection risk, dialysis arrangements, medicines and the likely benefit. Your renal team should remain involved in decisions that could affect ongoing treatment.
The first question is whether PRP is a sensible treatment for the joint or tendon diagnosis. The second is whether it can be planned safely in your circumstances. A provider should answer both before proposing a course of injections.
What does the 2025 consensus recommend?
The GRIIP formal consensus says PRP may be considered in people with chronic renal failure requiring dialysis, with careful monitoring for signs of bacteraemia, and that injection should be avoided on the day of dialysis. The recommendation is graded C, reflecting limited evidence rather than a large trial establishing a universally safe protocol. [1]
Bacteraemia means bacteria in the bloodstream. It is a clinical concern to assess, not a diagnosis to make from a symptom checklist at home. The recommendation does not mean every non-dialysis day is automatically suitable or that renal-team advice can be bypassed.
Ask The Wellness about a musculoskeletal PRP assessment and tell the team that you receive dialysis before arranging an appointment. A review may conclude that another treatment or a delay is more appropriate.
Why does timing need planning?
Dialysis is essential treatment with its own clinical arrangements. PRP should not interfere with attendance, access care or the renal team's instructions. The consensus specifically advises against injection on the dialysis day, but it does not provide a universal interval for every patient, dialysis method or medicine combination. [1]
Do not move a dialysis session or change a medicine to accommodate an elective injection without the renal team's agreement. The plan should be specific about timing and responsibility. A vague instruction to attend whenever you feel well is not enough.
Why is infection assessment important?
PRP is prepared from your own blood. That does not remove the possibility of infection related to the procedure or an infection already present. The consensus highlights careful assessment for bloodstream infection in this group. [1]
Tell the team about fever, chills, recent infection, antibiotics, new skin problems and concerns about your dialysis access. If you feel acutely unwell, use the renal service's urgent advice route or seek urgent medical care. Do not wait for a PRP assessment to investigate symptoms of serious illness.
The absence of fever alone is not a personalised clearance decision. Your clinician needs the full picture, including recent events and specialist advice. An elective procedure can be deferred while an unexplained concern is assessed.
What information should the renal team provide?
The PRP clinician may need a summary of the kidney condition, dialysis schedule, relevant medicines, recent blood results and any recent infection or access complication. With your consent, a focused exchange between clinicians can identify what needs to be checked before a decision.
A general letter saying you have kidney disease is not the same as an assessment of the proposed procedure. Ask what specific question remains unresolved and who will answer it. That makes the next step clearer and reduces repeated appointments without a decision.
Do medicines or blood counts change the plan?
They may. Bring the complete medicine list, including anticoagulants, antiplatelet medicines and treatments given around dialysis. Do not stop any of them yourself. The risks of changing essential treatment must be considered alongside the risks of the injection.
The consensus recommends investigation of significant blood-count abnormalities before PRP. A count should be interpreted in context; a platelet number alone does not capture every issue relevant to bleeding or the proposed procedure. [1]
The same consensus also states that it does not comprehensively address procedure-related bleeding risks or treatment interactions. Its dialysis recommendation cannot therefore be used as a complete checklist for every aspect of safety. [1]
Will PRP work for pain in someone on dialysis?
The dialysis suitability recommendation does not demonstrate efficacy. PRP evidence varies by the condition being treated, and trials may not represent people with complex kidney disease. A provider should explain that uncertainty rather than promising a predictable response. [1]
Pain also needs a diagnosis. Not all pain near a knee, shoulder or tendon is the same problem, and not every problem is appropriate for injection. Examination, previous imaging and the wider medical history may change the treatment discussion.
What should you ask about alternatives?
Ask whether rehabilitation, another medical approach or specialist assessment is more appropriate. Ask what benefit PRP might reasonably offer in your actual diagnosis, how long a trial would last and how the result would be measured.
The 2025 consensus recommends weighing the indication, lesion, medical history and treatments, while considering alternative injectable therapies. This does not mean every alternative is suitable for a person on dialysis. Each requires its own assessment. [1]
What should informed consent include?
You should understand the reason for treatment, the uncertainty in the evidence, procedural risks and the possibility of no meaningful benefit. Ask about the practical follow-up and whom to contact if pain, swelling or illness develops afterwards. The consent conversation should be tailored to your medical history, not reduced to a standard form. [1]
Do not commit to a package before the clinic has established whether it can assess and manage your circumstances. Clarify the assessment process and any proposed coordination with the renal team first.
A practical preparation list
Bring your dialysis schedule, renal-team contact details, medicines, recent blood results and records relating to the painful area. Include any recent hospital admission, infection or access problem. Ask for a written plan identifying what must happen before treatment can be considered.
Contact The Wellness to discuss assessment. A careful decision may be to treat, to investigate further or to choose another option. Avoiding an unsuitable procedure is a useful outcome of a specialist review.
Source and limits
[1] Eymard and colleagues: 2025 GRIIP formal consensus, including recommendation 7 and the stated scope limitations.
This article concerns musculoskeletal PRP, not hair or cosmetic treatment. The dialysis recommendation is based on limited evidence and is not individual medical clearance. Reviewed 31 October 2026.